DO NOT RECOMMENDtaking cilostazol during breastfeeding.
If you are pregnant or breastfeeding, or if you think you may be pregnant, or if you plan to become pregnant, consult your doctor or pharmacist before using this medication.
Driving and operating machinery
Cilostazol may cause dizziness. If you feel dizzy after taking cilostazol, DO NOT drive or operate any tools or machinery and inform your doctor or pharmacist.
You may notice the benefits of taking Cilostazol Viatris at 4-12 weeks of treatment. At 3 months of treatment, your doctor will evaluate your progress and may recommend that you stop taking cilostazol if the treatment effect is not sufficient.
Use in children and adolescents
Cilostazol Viatris is not suitable for children.
If you take more Cilostazol Viatris than you should
If you take any tablets of cilostazol for any reason more than you should, you may experience symptoms such as severe headache, diarrhea, low blood pressure, and irregular heartbeats.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take Cilostazol Viatris
Do not worry if you forget to take a dose. Wait until the next dose, take your next tablet, and continue treatment as usual. DO NOT take a double dose to compensate for the missed doses.
If you interrupt treatment with Cilostazol Viatris
If you stop taking cilostazol, the pain in your legs may return or worsen. Therefore, you should only stop taking cilostazol if you detect emergency medical attention required side effects (see section 4) or if your doctor advises you to do so.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications,thismedication may cause side effects, although not everyone will experience them.
If you experience any of the following side effects, you may need urgent medical attention. Stop taking Cilostazol Viatris and contact your doctor or go immediately to the nearest hospital.
You should also inform your doctor immediately if you experience fever or sore throat. Blood tests may be required; your doctor will decide on the treatment you should receive.
The following side effects have been observed with cilostazol. If you experience them, you should inform your doctor as soon as possible:
Very common side effects(may affect more than 1 in 10 people).
Common side effects(may affect up to 1 in 10 people).
Uncommon side effects(may affect up to 1 in 100 people).
Diabetics may be at a higher risk of eye bleeding.
Rare side effects(may affect up to 1 in 1000 people).
The following side effects have been observed during the use of cilostazol, but the frequency with which they occur is unknown.
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Vigilance of Medicines for Human Use:https://www.notificaram.es.By reporting these side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the carton box and the blister pack, after "CAD". The expiration date is the last day of the month indicated.
Do not use this medication if you detect visible signs of deterioration.
This medication does not require special storage conditions.
Medications should not be disposed of through drains or in the trash. Dispose of the containers and medications you no longer need at the SIGRE collection pointat the pharmacy. If in doubt, ask your pharmacist how to dispose of the containers and medications you no longer need. By doing so, you will help protect the environment.
Cilostazol Viatris Composition
The active ingredient is cilostazol. A tablet contains 100 mg of cilostazol.
The other ingredients are cornstarch, cellulose microcrystalline, calcium carmelose, hypromelose, and magnesium stearate.
Appearance of Cilostazol Viatris and packaging contents
The 100 mg Cilostazol Viatris tablet is white, off-white, round, flat-faced, and marked with "100" on one face.
This medication is supplied in packaging containing 7, 14, 20, 28, 30, 50, 56, 60, 98, and 100 tablets in PVC/PVDC/aluminum blisters.
Only some packaging sizes may be commercially available.
Marketing authorization holder and manufacturer
Marketing authorization holder:
Viatris Limited
Damastown Industrial Park
Mulhuddart, Dublin 15
Dublin
Ireland
Manufacturer:
Adamed Pharma S.A.
ul. Marszalka Józefa Pilsudskiego 5,
95-200 Pabianice
Poland
or
Terapia SA
Strada Fabricii nr. 124, Cluj-Napoca
Romania
Further information about this medication can be obtained by contacting the local representative of the marketing authorization holder:
Viatris Pharmaceuticals, S.L.U.
C/ General Aranaz, 86
28027 - Madrid
Spain
This medication is authorized in the European Economic Area member states with the following trade names:
Country | Trade name |
Slovakia | Cilozek 100 mg tablety |
Spain | Cilostazol Viatris 100 mg comprimidos EFG |
Estonia | Cilozek |
Greece | INCLAUD |
Hungary | Cilozek 100 mg tabletta |
Czech Republic | Claudienne 100 mg tablety |
Romania | VELYN 100 mg comprimate |
Poland | Cilozek |
Fechadelaúltimarevisióndeesteprospecto:April 2019
The detailed information about this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.